B1 Non-refereed article in a scientific journal

Reply to Xuefeng Liu's Letter to the Editor, re: Kimmo Kettunen, Peter J. Bostrom, Tarja Lamminen, et al. Personalized Drug Sensitivity Screening for Bladder Cancer Using Conditionally Reprogrammed Patient-derived Cells. Eur Urol 2019;76:430-4: Can Patient-derived Cancer Models Change the Costliest Cancer Type?




AuthorsKimmo Kettunen, Peter Boström, Pekka Taimen

PublisherELSEVIER

Publication year2020

JournalEuropean Urology

Journal name in sourceEUROPEAN UROLOGY

Journal acronymEUR UROL

Volume77

Issue1

First page E23

Last pageE23

Number of pages1

ISSN0302-2838

eISSN1873-7560

DOIhttps://doi.org/10.1016/j.eururo.2019.09.011




Last updated on 2024-26-11 at 21:29